Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CYTK
CYTOKINETICS INC
NASDAQ · Pharmaceutical Preparations
Last close
$65.91
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$9.16B
RECENT INSIDER TRADES
2026-10-06
· Malik Fady Ibraham
(EVP Research & Development)
· OTHER
2026-10-06
· Malik Fady Ibraham
(EVP Research & Development)
· SELL
2026-09-28
· Blum Robert I
(President & CEO)
· SELL
2026-09-28
· Blum Robert I
(President & CEO)
· OTHER
2026-09-22
· Malik Fady Ibraham
(EVP Research & Development)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
518
Shares held
191,580,798
Value
$13.52B
Percent of shares outstanding
137.80%
As of quarter end
2026-06-30
RECENT CONGRESSIONAL TRADES
2026-06-30
· Gilbert Cisneros · BUY
· $1,001 - $15,000
RECENT NEWS
Cytokinetics EVP Fady Malik sells $214,830 in company stock
Cytokinetics to present four studies at HFSA Annual Scientific Meeting 2026
Cytokinetics launches real-world study of heart drug MYQORZO
Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story?
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
CYTOKINETICS INC (CYTK) · Stock Price, Insider Trades, Congress Trades · CatalystPit